Compounds > xanthorrhizol
Page last updated: 2024-08-26

xanthorrhizol and Experimental Neoplasms

xanthorrhizol has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, JM; Chung, WY; Hwang, JK; Kim, du S; Kim, JY; Park, KK; Seo, JT; Seo, SR1
Choi, MA; Chung, WY; Hwang, JK; Kim, SH; Park, KK1

Other Studies

2 other study(ies) available for xanthorrhizol and Experimental Neoplasms

ArticleYear
Xanthorrhizol induces apoptosis through ROS-mediated MAPK activation in human oral squamous cell carcinoma cells and inhibits DMBA-induced oral carcinogenesis in hamsters.
    Phytotherapy research : PTR, 2013, Volume: 27, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Cricetinae; Humans; Male; MAP Kinase Signaling System; Mouth Neoplasms; Neoplasms, Experimental; Phenols; Reactive Oxygen Species

2013
Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model.
    Biochemical and biophysical research communications, 2005, Jan-07, Volume: 326, Issue:1

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Curcuma; Dose-Response Relationship, Drug; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Phenols; Phytotherapy; Plant Extracts; Treatment Outcome

2005